Skip to main content
Top
Published in: BMC Cancer 1/2011

Open Access 01-12-2011 | Research article

Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control study

Authors: Fu-Hsiung Su, Shih-Ni Chang, Pei-Chun Chen, Fung-Chang Sung, Chien-Tien Su, Chih-Ching Yeh

Published in: BMC Cancer | Issue 1/2011

Login to get access

Abstract

Background

In Taiwan, there is a high incidence of breast cancer and a high prevalence of viral hepatitis. In this case-control study, we used a population-based insurance dataset to evaluate whether breast cancer in women is associated with chronic viral hepatitis infection.

Methods

From the claims data, we identified 1,958 patients with newly diagnosed breast cancer during the period 2000-2008. A randomly selected, age-matched cohort of 7,832 subjects without cancer was selected for comparison. Multivariable logistic regression models were constructed to calculate odds ratios of breast cancer associated with viral hepatitis after adjustment for age, residential area, occupation, urbanization, and income. The age-specific (<50 years and ≥50 years) risk of breast cancer was also evaluated.

Results

There were no significant differences in the prevalence of hepatitis C virus (HCV) infection, hepatitis B virus (HBV), or the prevalence of combined HBC/HBV infection between breast cancer patients and control subjects (p = 0.48). Multivariable logistic regression analysis, however, revealed that age <50 years was associated with a 2-fold greater risk of developing breast cancer (OR = 2.03, 95% CI = 1.23-3.34).

Conclusions

HCV infection, but not HBV infection, appears to be associated with early onset risk of breast cancer in areas endemic for HCV and HBV. This finding needs to be replicated in further studies.
Literature
1.
go back to reference Hortobagyi GN, de la Garza Salazar J, Pritchard K, Amadori D, Haidinger R, Hudis CA, Khaled H, Liu MC, Martin M, Namer M, et al: The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer. 2005, 6 (5): 391-401. 10.3816/CBC.2005.n.043.CrossRefPubMed Hortobagyi GN, de la Garza Salazar J, Pritchard K, Amadori D, Haidinger R, Hudis CA, Khaled H, Liu MC, Martin M, Namer M, et al: The global breast cancer burden: variations in epidemiology and survival. Clin Breast Cancer. 2005, 6 (5): 391-401. 10.3816/CBC.2005.n.043.CrossRefPubMed
2.
go back to reference Leong SP, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik NS, Sandelin K, Derossis A, Cody H, Foulkes WD: Is breast cancer the same disease in Asian and Western countries?. World J Surg. 2010, 34 (10): 2308-2324. 10.1007/s00268-010-0683-1.CrossRefPubMedPubMedCentral Leong SP, Shen ZZ, Liu TJ, Agarwal G, Tajima T, Paik NS, Sandelin K, Derossis A, Cody H, Foulkes WD: Is breast cancer the same disease in Asian and Western countries?. World J Surg. 2010, 34 (10): 2308-2324. 10.1007/s00268-010-0683-1.CrossRefPubMedPubMedCentral
3.
go back to reference Pollan M: Epidemiology of breast cancer in young women. Breast Cancer Res Treat. 2010, 123 (Suppl 1): 3-6.CrossRefPubMed Pollan M: Epidemiology of breast cancer in young women. Breast Cancer Res Treat. 2010, 123 (Suppl 1): 3-6.CrossRefPubMed
4.
go back to reference Huang CS, Lin CH, Lu YS, Shen CY: Unique features of breast cancer in Asian women--breast cancer in Taiwan as an example. J Steroid Biochem Mol Biol. 2010, 118 (4-5): 300-303. 10.1016/j.jsbmb.2009.12.017.CrossRefPubMed Huang CS, Lin CH, Lu YS, Shen CY: Unique features of breast cancer in Asian women--breast cancer in Taiwan as an example. J Steroid Biochem Mol Biol. 2010, 118 (4-5): 300-303. 10.1016/j.jsbmb.2009.12.017.CrossRefPubMed
5.
go back to reference Lim SE, Back M, Quek E, Iau P, Putti T, Wong JE: Clinical observations from a breast cancer registry in Asian women. World J Surg. 2007, 31 (7): 1387-1392. 10.1007/s00268-007-9086-3.CrossRefPubMed Lim SE, Back M, Quek E, Iau P, Putti T, Wong JE: Clinical observations from a breast cancer registry in Asian women. World J Surg. 2007, 31 (7): 1387-1392. 10.1007/s00268-007-9086-3.CrossRefPubMed
6.
go back to reference Casey PM, Cerhan JR, Pruthi S: Oral contraceptive use and risk of breast cancer. Mayo Clinic proceedings Mayo Clinic. 2008, 83 (1): 86-90. quiz 90-81CrossRef Casey PM, Cerhan JR, Pruthi S: Oral contraceptive use and risk of breast cancer. Mayo Clinic proceedings Mayo Clinic. 2008, 83 (1): 86-90. quiz 90-81CrossRef
7.
go back to reference Hamilton R, Williams JK, Bowers BJ, Calzone K: Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer. Journal of genetic counseling. 2009, 18 (2): 147-159. 10.1007/s10897-008-9200-1.CrossRefPubMed Hamilton R, Williams JK, Bowers BJ, Calzone K: Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer. Journal of genetic counseling. 2009, 18 (2): 147-159. 10.1007/s10897-008-9200-1.CrossRefPubMed
8.
go back to reference Lajous M, Boutron-Ruault MC, Fabre A, Clavel-Chapelon F, Romieu I: Carbohydrate intake, glycemic index, glycemic load, and risk of postmenopausal breast cancer in a prospective study of French women. The American journal of clinical nutrition. 2008, 87 (5): 1384-1391.PubMed Lajous M, Boutron-Ruault MC, Fabre A, Clavel-Chapelon F, Romieu I: Carbohydrate intake, glycemic index, glycemic load, and risk of postmenopausal breast cancer in a prospective study of French women. The American journal of clinical nutrition. 2008, 87 (5): 1384-1391.PubMed
9.
go back to reference Terry KL, Willett WC, Rich-Edwards JW, Michels KB: A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer. Archives of internal medicine. 2006, 166 (22): 2484-2489. 10.1001/archinte.166.22.2484.CrossRefPubMed Terry KL, Willett WC, Rich-Edwards JW, Michels KB: A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer. Archives of internal medicine. 2006, 166 (22): 2484-2489. 10.1001/archinte.166.22.2484.CrossRefPubMed
10.
go back to reference Richardson A: Is breast cancer caused by late exposure to a common virus?. Med Hypotheses. 1997, 48 (6): 491-497. 10.1016/S0306-9877(97)90118-3.CrossRefPubMed Richardson A: Is breast cancer caused by late exposure to a common virus?. Med Hypotheses. 1997, 48 (6): 491-497. 10.1016/S0306-9877(97)90118-3.CrossRefPubMed
11.
go back to reference Zur Hausen H: The search for infectious causes of human cancers: where and why. Virology. 2009, 392 (1): 1-10. 10.1016/j.virol.2009.06.001.CrossRefPubMed Zur Hausen H: The search for infectious causes of human cancers: where and why. Virology. 2009, 392 (1): 1-10. 10.1016/j.virol.2009.06.001.CrossRefPubMed
12.
go back to reference de Villiers EM, Sandstrom RE, zur Hausen H, Buck CE: Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res: BCR. 2005, 7 (1): R1-11.CrossRefPubMed de Villiers EM, Sandstrom RE, zur Hausen H, Buck CE: Presence of papillomavirus sequences in condylomatous lesions of the mamillae and in invasive carcinoma of the breast. Breast Cancer Res: BCR. 2005, 7 (1): R1-11.CrossRefPubMed
13.
go back to reference Glaser SL, Hsu JL, Gulley ML: Epstein-Barr virus and breast cancer: state of the evidence for viral carcinogenesis. Cancer Epidemiol Biomarkers Prev. 2004, 13 (5): 688-697.PubMed Glaser SL, Hsu JL, Gulley ML: Epstein-Barr virus and breast cancer: state of the evidence for viral carcinogenesis. Cancer Epidemiol Biomarkers Prev. 2004, 13 (5): 688-697.PubMed
14.
go back to reference Yasui Y, Potter JD, Stanford JL, Rossing MA, Winget MD, Bronner M, Daling J: Breast cancer risk and "delayed" primary Epstein-Barr virus infection. Cancer Epidemiol Biomarkers Prev. 2001, 10 (1): 9-16.PubMed Yasui Y, Potter JD, Stanford JL, Rossing MA, Winget MD, Bronner M, Daling J: Breast cancer risk and "delayed" primary Epstein-Barr virus infection. Cancer Epidemiol Biomarkers Prev. 2001, 10 (1): 9-16.PubMed
15.
go back to reference Mazouni C, Fina F, Romain S, Ouafik L, Bonnier P, Brandone JM, Martin PM: Epstein-Barr virus as a marker of biological aggressiveness in breast cancer. Br J Cancer. 2011, 104 (2): 332-337. 10.1038/sj.bjc.6606048.CrossRefPubMed Mazouni C, Fina F, Romain S, Ouafik L, Bonnier P, Brandone JM, Martin PM: Epstein-Barr virus as a marker of biological aggressiveness in breast cancer. Br J Cancer. 2011, 104 (2): 332-337. 10.1038/sj.bjc.6606048.CrossRefPubMed
16.
go back to reference Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, Engels EA: Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA. 2007, 297 (18): 2010-2017. 10.1001/jama.297.18.2010.CrossRefPubMed Giordano TP, Henderson L, Landgren O, Chiao EY, Kramer JR, El-Serag H, Engels EA: Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus. JAMA. 2007, 297 (18): 2010-2017. 10.1001/jama.297.18.2010.CrossRefPubMed
17.
go back to reference Omland LH, Farkas DK, Jepsen P, Obel N, Pedersen L: Hepatitis C virus infection and risk of cancer: a population-based cohort study. Clin Epidemiol. 2010, 2: 179-186.CrossRefPubMedPubMedCentral Omland LH, Farkas DK, Jepsen P, Obel N, Pedersen L: Hepatitis C virus infection and risk of cancer: a population-based cohort study. Clin Epidemiol. 2010, 2: 179-186.CrossRefPubMedPubMedCentral
18.
go back to reference Iloeje UH, Yang HI, Jen CL, Su J, Wang LY, You SL, Lu SN, Chen CJ: Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study. Liver Int. 2010, 30 (3): 423-429. 10.1111/j.1478-3231.2009.02147.x.CrossRefPubMed Iloeje UH, Yang HI, Jen CL, Su J, Wang LY, You SL, Lu SN, Chen CJ: Risk of pancreatic cancer in chronic hepatitis B virus infection: data from the REVEAL-HBV cohort study. Liver Int. 2010, 30 (3): 423-429. 10.1111/j.1478-3231.2009.02147.x.CrossRefPubMed
19.
go back to reference Engels EA, Cho ER, Jee SH: Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol. 2010, 11 (9): 827-834. 10.1016/S1470-2045(10)70167-4.CrossRefPubMedPubMedCentral Engels EA, Cho ER, Jee SH: Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol. 2010, 11 (9): 827-834. 10.1016/S1470-2045(10)70167-4.CrossRefPubMedPubMedCentral
20.
go back to reference Fwu CW, Chien YC, You SL, Nelson KE, Kirk GD, Kuo HS, Feinleib M, Chen CJ: Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan. Hepatology. 2011, 53 (4): 1217-1225. 10.1002/hep.24150.CrossRefPubMed Fwu CW, Chien YC, You SL, Nelson KE, Kirk GD, Kuo HS, Feinleib M, Chen CJ: Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan. Hepatology. 2011, 53 (4): 1217-1225. 10.1002/hep.24150.CrossRefPubMed
21.
go back to reference Chang KJ, Kuo WH, Wang MY: The epidemiology of breast cancer inTaiwan. J Chinese Oncol Soc. 2008, 24 (2): 85-93. Chang KJ, Kuo WH, Wang MY: The epidemiology of breast cancer inTaiwan. J Chinese Oncol Soc. 2008, 24 (2): 85-93.
22.
go back to reference Tsai MC, Kee KM, Chen YD, Lin LC, Tsai LS, Chen HH, Lu SN: Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan. J Gastroenterol Hepatol. 2007, 22 (1): 92-98. 10.1111/j.1440-1746.2006.04489.x.CrossRefPubMed Tsai MC, Kee KM, Chen YD, Lin LC, Tsai LS, Chen HH, Lu SN: Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan. J Gastroenterol Hepatol. 2007, 22 (1): 92-98. 10.1111/j.1440-1746.2006.04489.x.CrossRefPubMed
23.
go back to reference Lu JF, Hsiao WC: Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Aff (Millwood). 2003, 22 (3): 77-88. 10.1377/hlthaff.22.3.77.CrossRef Lu JF, Hsiao WC: Does universal health insurance make health care unaffordable? Lessons from Taiwan. Health Aff (Millwood). 2003, 22 (3): 77-88. 10.1377/hlthaff.22.3.77.CrossRef
24.
go back to reference Liang SH, Chen TJ, Lee SS, Tseng FC, Huang CK, Lai CH, Chiou CP, Wang JL, Chung HC, Lin JN, et al: Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection. J Acquir Immune Defic Syndr. 2010, 54 (2): 122-128.PubMed Liang SH, Chen TJ, Lee SS, Tseng FC, Huang CK, Lai CH, Chiou CP, Wang JL, Chung HC, Lin JN, et al: Risk factors of isolated antibody against core antigen of hepatitis B virus: association with HIV infection and age but not hepatitis C virus infection. J Acquir Immune Defic Syndr. 2010, 54 (2): 122-128.PubMed
25.
go back to reference Anderson WF, Matsuno R: Breast cancer heterogeneity: a mixture of at least two main types?. J Natl Cancer Inst. 2006, 98 (14): 948-951. 10.1093/jnci/djj295.CrossRefPubMed Anderson WF, Matsuno R: Breast cancer heterogeneity: a mixture of at least two main types?. J Natl Cancer Inst. 2006, 98 (14): 948-951. 10.1093/jnci/djj295.CrossRefPubMed
26.
go back to reference Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS: Spectrum of breast cancer in Asian women. World J Surg. 2007, 31 (5): 1031-1040. 10.1007/s00268-005-0585-9.CrossRefPubMed Agarwal G, Pradeep PV, Aggarwal V, Yip CH, Cheung PS: Spectrum of breast cancer in Asian women. World J Surg. 2007, 31 (5): 1031-1040. 10.1007/s00268-005-0585-9.CrossRefPubMed
27.
go back to reference Kuo WH, Yen AM, Lee PH, Hou MF, Chen SC, Chen KM, Chen TH, Chang KJ: Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan. Breast Cancer Res Treat. 2006, 99 (2): 221-228. 10.1007/s10549-006-9194-z.CrossRefPubMed Kuo WH, Yen AM, Lee PH, Hou MF, Chen SC, Chen KM, Chen TH, Chang KJ: Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan. Breast Cancer Res Treat. 2006, 99 (2): 221-228. 10.1007/s10549-006-9194-z.CrossRefPubMed
28.
go back to reference Richardson AK, Cox B, McCredie MR, Dite GS, Chang JH, Gertig DM, Southey MC, Giles GG, Hopper JL: Cytomegalovirus, Epstein-Barr virus and risk of breast cancer before age 40 years: a case-control study. Br J Cancer. 2004, 90 (11): 2149-2152.PubMedPubMedCentral Richardson AK, Cox B, McCredie MR, Dite GS, Chang JH, Gertig DM, Southey MC, Giles GG, Hopper JL: Cytomegalovirus, Epstein-Barr virus and risk of breast cancer before age 40 years: a case-control study. Br J Cancer. 2004, 90 (11): 2149-2152.PubMedPubMedCentral
29.
go back to reference Wang T, Chang P, Wang L, Yao Q, Guo W, Chen J, Yan T, Cao C: The role of human papillomavirus infection in breast cancer. Med Oncol. 2011 Wang T, Chang P, Wang L, Yao Q, Guo W, Chen J, Yan T, Cao C: The role of human papillomavirus infection in breast cancer. Med Oncol. 2011
30.
go back to reference Malaguarnera M, Gargante MP, Risino C, Ranno S, Berretta M, Cannizzaro MA, Costanzo M, Fricia T, Rampello E, Romano M: Hepatitis C virus in elderly cancer patients. European journal of internal medicine. 2006, 17 (5): 325-329. 10.1016/j.ejim.2006.02.004.CrossRefPubMed Malaguarnera M, Gargante MP, Risino C, Ranno S, Berretta M, Cannizzaro MA, Costanzo M, Fricia T, Rampello E, Romano M: Hepatitis C virus in elderly cancer patients. European journal of internal medicine. 2006, 17 (5): 325-329. 10.1016/j.ejim.2006.02.004.CrossRefPubMed
31.
go back to reference Larrey D, Bozonnat MC, Kain I, Pageaux GP, Assenat E: Is chronic hepatitis C virus infection a risk factor for breast cancer?. World J Gastroenterol. 2010, 16 (29): 3687-3691. 10.3748/wjg.v16.i29.3687.CrossRefPubMedPubMedCentral Larrey D, Bozonnat MC, Kain I, Pageaux GP, Assenat E: Is chronic hepatitis C virus infection a risk factor for breast cancer?. World J Gastroenterol. 2010, 16 (29): 3687-3691. 10.3748/wjg.v16.i29.3687.CrossRefPubMedPubMedCentral
32.
go back to reference Bruno G, Andreozzi P, Graf U, Santangelo G: Hepatitis C virus: a high risk factor for a second primary malignancy besides hepatocellular carcinoma. Fact or fiction?. Clin Ter. 1999, 150 (6): 413-418.PubMed Bruno G, Andreozzi P, Graf U, Santangelo G: Hepatitis C virus: a high risk factor for a second primary malignancy besides hepatocellular carcinoma. Fact or fiction?. Clin Ter. 1999, 150 (6): 413-418.PubMed
33.
go back to reference Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP: The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006, 45 (4): 529-538. 10.1016/j.jhep.2006.05.013.CrossRefPubMed Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP: The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006, 45 (4): 529-538. 10.1016/j.jhep.2006.05.013.CrossRefPubMed
34.
go back to reference Cacoub P, Fabiani FL, Musset L, Perrin M, Frangeul L, Leger JM, Huraux JM, Piette JC, Godeau P: Mixed cryoglobulinemia and hepatitis C virus. Am J Med. 1994, 96 (2): 124-132. 10.1016/0002-9343(94)90132-5.CrossRefPubMed Cacoub P, Fabiani FL, Musset L, Perrin M, Frangeul L, Leger JM, Huraux JM, Piette JC, Godeau P: Mixed cryoglobulinemia and hepatitis C virus. Am J Med. 1994, 96 (2): 124-132. 10.1016/0002-9343(94)90132-5.CrossRefPubMed
35.
go back to reference Neri S, Ierna D, Mauceri B, Abate G, Cilio D, Bordonaro F, Calvagno S, Balsamo D, Pulvirenti D, Magliocco O, et al: Can ultrasonographic findings of perihepatic lymphadenopathy promote investigations to detect possible presence of virus C infection in non-symptomatic subjects?. Hepatol Res. 2003, 27 (2): 124-128. 10.1016/S1386-6346(03)00198-0.CrossRefPubMed Neri S, Ierna D, Mauceri B, Abate G, Cilio D, Bordonaro F, Calvagno S, Balsamo D, Pulvirenti D, Magliocco O, et al: Can ultrasonographic findings of perihepatic lymphadenopathy promote investigations to detect possible presence of virus C infection in non-symptomatic subjects?. Hepatol Res. 2003, 27 (2): 124-128. 10.1016/S1386-6346(03)00198-0.CrossRefPubMed
36.
go back to reference Shepard CW, Finelli L, Alter MJ: Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005, 5 (9): 558-567. 10.1016/S1473-3099(05)70216-4.CrossRefPubMed Shepard CW, Finelli L, Alter MJ: Global epidemiology of hepatitis C virus infection. Lancet Infect Dis. 2005, 5 (9): 558-567. 10.1016/S1473-3099(05)70216-4.CrossRefPubMed
37.
go back to reference Gumber SC, Chopra S: Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med. 1995, 123 (8): 615-620.CrossRefPubMed Gumber SC, Chopra S: Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med. 1995, 123 (8): 615-620.CrossRefPubMed
38.
go back to reference Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB: Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis. 2007, 39 (1): 2-17. 10.1016/j.dld.2006.06.008.CrossRefPubMed Zignego AL, Ferri C, Pileri SA, Caini P, Bianchi FB: Extrahepatic manifestations of Hepatitis C Virus infection: a general overview and guidelines for a clinical approach. Dig Liver Dis. 2007, 39 (1): 2-17. 10.1016/j.dld.2006.06.008.CrossRefPubMed
39.
go back to reference Hadziyannis SJ: Nonhepatic manifestations and combined diseases in HCV infection. Dig Dis Sci. 1996, 41 (12 Suppl): 63S-74S.CrossRefPubMed Hadziyannis SJ: Nonhepatic manifestations and combined diseases in HCV infection. Dig Dis Sci. 1996, 41 (12 Suppl): 63S-74S.CrossRefPubMed
40.
go back to reference Agnello V, De Rosa FG: Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol. 2004, 40 (2): 341-352. 10.1016/j.jhep.2003.10.009.CrossRefPubMed Agnello V, De Rosa FG: Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol. 2004, 40 (2): 341-352. 10.1016/j.jhep.2003.10.009.CrossRefPubMed
Metadata
Title
Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control study
Authors
Fu-Hsiung Su
Shih-Ni Chang
Pei-Chun Chen
Fung-Chang Sung
Chien-Tien Su
Chih-Ching Yeh
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2011
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-11-495

Other articles of this Issue 1/2011

BMC Cancer 1/2011 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine